ADORA1 is involved in promoting tumor growth through bone marrow-derived suppressor cells and has been reported to support tumor growth outcomes in colorectal adenocarcinoma, human leukemia Jurkat cells, breast cancer and kidney cancer. This evidence concerns the gene ADORA1 and colorectal adenocarcinoma.